2024 Q3 Form 10-Q Financial Statement

#000149269124000080 Filed on July 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.877B $1.847B
YoY Change -7.09% 18.91%
Cost Of Revenue $651.2M $647.6M
YoY Change -12.71% 22.66%
Gross Profit $1.226B $1.199B
YoY Change -3.81% 16.98%
Gross Profit Margin 65.3% 64.93%
Selling, General & Admin $863.6M $849.1M
YoY Change -4.89% 22.57%
% of Gross Profit 70.47% 70.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $197.5M $197.4M
YoY Change 11.84% 14.18%
% of Gross Profit 16.12% 16.46%
Operating Expenses $1.142B $1.129B
YoY Change -3.42% 22.15%
Operating Profit $83.40M $69.98M
YoY Change 2.89% -30.49%
Interest Expense -$40.39M -$36.67M
YoY Change -202.64% 94.55%
% of Operating Profit -48.44% -52.4%
Other Income/Expense, Net $3.169M $4.888M
YoY Change -114.16% -49.5%
Pretax Income $44.20M $31.68M
YoY Change -24.68% -62.67%
Income Tax $14.14M $11.79M
% Of Pretax Income 31.99% 37.21%
Net Earnings $30.46M $20.30M
YoY Change -49.39% -67.94%
Net Earnings / Revenue 1.62% 1.1%
Basic Earnings Per Share $0.19 $0.13
Diluted Earnings Per Share $0.19 $0.13
COMMON SHARES
Basic Shares Outstanding 161.9M shares 161.6M shares
Diluted Shares Outstanding 162.2M shares 162.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.3M $186.5M
YoY Change -13.81% -18.56%
Cash & Equivalents $166.3M $186.5M
Short-Term Investments
Other Short-Term Assets $389.8M $382.9M
YoY Change 626.17% -58.68%
Inventory
Prepaid Expenses $114.8M $113.0M
Receivables $835.2M $841.6M
Other Receivables $46.19M $39.27M
Total Short-Term Assets $1.438B $1.450B
YoY Change -18.37% -23.07%
LONG-TERM ASSETS
Property, Plant & Equipment $5.175B $5.047B
YoY Change 14.88% 21.24%
Goodwill $3.963B $3.879B
YoY Change 3.09% 10.23%
Intangibles $2.075B $2.022B
YoY Change -0.1% 15.93%
Long-Term Investments
YoY Change
Other Assets $173.9M $171.8M
YoY Change 18.14% 35.77%
Total Long-Term Assets $11.39B $11.12B
YoY Change 2.78% 16.41%
TOTAL ASSETS
Total Short-Term Assets $1.438B $1.450B
Total Long-Term Assets $11.39B $11.12B
Total Assets $12.82B $12.57B
YoY Change -0.12% 9.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $293.2M $300.6M
YoY Change -1.94% 34.5%
Accrued Expenses $527.9M $505.1M
YoY Change 131.07% 78.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $272.4M $485.9M
YoY Change -37.39% 562.87%
Total Short-Term Liabilities $1.430B $1.650B
YoY Change -17.39% 74.54%
LONG-TERM LIABILITIES
Long-Term Debt $2.654B $2.180B
YoY Change 18.29% 1.52%
Other Long-Term Liabilities $754.0M $759.4M
YoY Change 945.19% 108.24%
Total Long-Term Liabilities $3.408B $2.939B
YoY Change 4624.52% 17.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.430B $1.650B
Total Long-Term Liabilities $3.408B $2.939B
Total Liabilities $5.766B $5.516B
YoY Change 0.97% 26.3%
SHAREHOLDERS EQUITY
Retained Earnings $2.618B $2.614B
YoY Change -2.81% -1.65%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.059B $7.054B
YoY Change
Total Liabilities & Shareholders Equity $12.82B $12.57B
YoY Change -0.12% 9.9%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $30.46M $20.30M
YoY Change -49.39% -67.94%
Depreciation, Depletion And Amortization $197.5M $197.4M
YoY Change 11.84% 14.18%
Cash From Operating Activities $214.0M $273.4M
YoY Change 41.47% -27.48%
INVESTING ACTIVITIES
Capital Expenditures $219.4M $180.8M
YoY Change -34.46% -29.81%
Acquisitions
YoY Change
Other Investing Activities -$140.8M $61.66M
YoY Change -58.27% 58.79%
Cash From Investing Activities -$360.2M -$119.1M
YoY Change -46.4% -45.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 127.8M -160.1M
YoY Change 158.17% -143.12%
NET CHANGE
Cash From Operating Activities 214.0M 273.4M
Cash From Investing Activities -360.2M -119.1M
Cash From Financing Activities 127.8M -160.1M
Net Change In Cash -18.35M -5.734M
YoY Change -96.11% -101.08%
FREE CASH FLOW
Cash From Operating Activities $214.0M $273.4M
Capital Expenditures $219.4M $180.8M
Free Cash Flow -$5.379M $92.67M
YoY Change -97.07% -22.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Interest Expense
InterestExpense
40482000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
24354000 usd
us-gaap Interest Expense
InterestExpense
81718000 usd
us-gaap Interest Expense
InterestExpense
47445000 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161836000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161836000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161385000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161385000 shares
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
664000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-155000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-258841000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-415990000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
100147000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
38148000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
250000000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
53000000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
167000000 usd
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
22000000 usd
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
0 usd
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
96600000 usd
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
80000000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3108000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3222000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
52342000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
45940000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11307000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-19510000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-182288000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
236624000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-130429000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
542824000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
469686000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
385345000 usd
us-gaap Interest Paid Net
InterestPaidNet
86931000 usd
us-gaap Interest Paid Net
InterestPaidNet
45851000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7695000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16870000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29444000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30789000 usd
knx Right Of Use Asset Forfeited Obtained In Exchange For Operating Lease Liability
RightOfUseAssetForfeitedObtainedInExchangeForOperatingLeaseLiability
25247000 usd
knx Right Of Use Asset Forfeited Obtained In Exchange For Operating Lease Liability
RightOfUseAssetForfeitedObtainedInExchangeForOperatingLeaseLiability
30564000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
77472000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
19797000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186473000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168545000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228957000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196770000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
149571000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
297275000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
251438000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
185792000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3213000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3866000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3117000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2783000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339257000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
469686000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
928169000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
385345000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7104081000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1206000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1898000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11651000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10581000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
us-gaap Dividends
Dividends
52085000 usd
us-gaap Profit Loss
ProfitLoss
16900000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1473000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2057000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7070353000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
163000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
977000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2082000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
18271000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16587000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
us-gaap Dividends
Dividends
45491000 usd
us-gaap Profit Loss
ProfitLoss
166617000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1621000 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1716000 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1716000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
239000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7081043000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7072222000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1208000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
945000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5216000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6600000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q2 us-gaap Dividends
Dividends
26066000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
19893000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41000 usd
CY2024Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
743000 usd
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
19000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7070353000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
977000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1042000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6523000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8660000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q2 us-gaap Dividends
Dividends
22761000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
62904000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
531000 usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
741000 usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
741000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
239000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7081043000 usd
CY2024Q2 knx Numberof Tractors In Fleet
NumberofTractorsInFleet
23071 vehicle
CY2024Q2 knx Number Of Tractors Driven By Company Drivers
NumberOfTractorsDrivenByCompanyDrivers
20913 vehicle
CY2024Q2 knx Number Of Owner Operator Tractors
NumberOfOwnerOperatorTractors
2158 vehicle
CY2024Q2 knx Number Of Trailers In Fleet
NumberOfTrailersInFleet
93495 vehicle
CY2024Q2 knx Number Of Ltl Tractors
NumberOfLTLTractors
3393 vehicle
CY2024Q2 knx Number Of Ltl Trailers
NumberOfLTLTrailers
8796 vehicle
CY2024Q2 knx Number Of Intermodal Tractors
NumberOfIntermodalTractors
611 vehicle
CY2024Q2 knx Number Of Intermodal Containers
NumberOfIntermodalContainers
12581 vehicle
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.372
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10400000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10400000 usd
CY2024Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q2 us-gaap Open Tax Year
OpenTaxYear
2018
CY2024Q2 us-gaap Unsecured Debt
UnsecuredDebt
1523946000 usd
CY2023Q4 us-gaap Unsecured Debt
UnsecuredDebt
1561079000 usd
CY2024Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
350825000 usd
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
338058000 usd
CY2024Q2 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1173121000 usd
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1223021000 usd
CY2024Q2 us-gaap Unsecured Debt
UnsecuredDebt
1523946000 usd
CY2023Q4 us-gaap Unsecured Debt
UnsecuredDebt
1561079000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1643946000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1628079000 usd
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
265000000.0 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
264300000 usd
CY2024Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0525
CY2024Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0503
CY2023Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0465
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0486
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0476
CY2024Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
CY2023Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
6600000 usd
us-gaap Payments For Reinsurance
PaymentsForReinsurance
161100000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161689000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161116000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161598000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161018000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
422000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
824000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
491000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
899000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162111000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161940000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162089000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161917000 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
525000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
110000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
378000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61000 shares
CY2024Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
120161000 usd
CY2024Q2 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
120161000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
102252000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
102252000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
40859000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
40859000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
40859000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
40859000 usd
CY2024Q2 us-gaap Revenues
Revenues
1846654000 usd
CY2023Q2 us-gaap Revenues
Revenues
1552979000 usd
us-gaap Revenues
Revenues
3669121000 usd
us-gaap Revenues
Revenues
3189911000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
63460000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
94030000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
84015000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
238817000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
178850000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
156381000 usd
us-gaap Depreciation
Depreciation
360715000 usd
us-gaap Depreciation
Depreciation
312347000 usd
CY2024Q2 knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
CY2023Q2 knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
CY2023Q4 knx Longlivedassetsofforeignoperations
Longlivedassetsofforeignoperations
0.050
CY2024Q2 knx Longlivedassetsofforeignoperations
Longlivedassetsofforeignoperations
0.050

Files In Submission

Name View Source Status
0001492691-24-000080-index-headers.html Edgar Link pending
0001492691-24-000080-index.html Edgar Link pending
0001492691-24-000080.txt Edgar Link pending
0001492691-24-000080-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knx-20240630.htm Edgar Link pending
knx-20240630.xsd Edgar Link pending
knx-20240630_g1.jpg Edgar Link pending
knx-ex311x6302024.htm Edgar Link pending
knx-ex312x6302024.htm Edgar Link pending
knx-ex321x6302024.htm Edgar Link pending
knx-ex322x6302024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
knx-20240630_cal.xml Edgar Link unprocessable
knx-20240630_def.xml Edgar Link unprocessable
knx-20240630_lab.xml Edgar Link unprocessable
knx-20240630_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
knx-20240630_pre.xml Edgar Link unprocessable